Actinium Pharmaceuticals Announces Actimab-A Intellectual Property and Manufacturing Advances and Provides NYSE American Listing Update

Summary

Actinium Pharmaceuticals announced intellectual property and manufacturing advances for its Actimab-A program, along with a NYSE American listing update. The announcement represents routine progress updates on the company's targeted radiotherapy pipeline.